BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 15817270)

  • 1. Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study.
    Lessard A; Campos MM; Neugebauer W; Couture R
    Br J Pharmacol; 2003 Feb; 138(4):554-63. PubMed ID: 12598409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular injections of tachykinin NK3 receptor agonists suppress the intake of "salty" tastes by sodium deficient rats.
    Flynn FW
    Behav Brain Res; 2006 Jan; 166(1):1-8. PubMed ID: 16154648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central injection of senktide, an NK3 receptor agonist, or neuropeptide Y inhibits LH secretion and induces different patterns of Fos expression in the rat hypothalamus.
    Sandoval-Guzmán T; Rance NE
    Brain Res; 2004 Nov; 1026(2):307-12. PubMed ID: 15488494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral ventricular injections of the NK3 agonist senktide affect salt taste-elicited responses.
    Flynn FW; Smith ME
    Peptides; 1998; 19(2):319-24. PubMed ID: 9493864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular injections of tachykinin NK3 receptor agonist reduce the gain of the baroreflex in unrestrained rats.
    Flynn FW
    Exp Neurol; 2005 May; 193(1):118-24. PubMed ID: 15817270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmented baroreflex sensitivity by vasopressin].
    Kuwaki T
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():497-501. PubMed ID: 15813117
    [No Abstract]   [Full Text] [Related]  

  • 9. [Invasive and non-invasive assessment of baroreflexes: redundant or complementary information?].
    Pitzalis MV; Massari F; Rizzon P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):765-7. PubMed ID: 12497818
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.